BSX vs MGLD · P/E 20, rev $10.65B vs rev $30.2M
Boston Scientific Corp (BSX) versus Marygold Companies Inc (MGLD) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Marygold Companies Inc (MGLD) is a asset management company listed on AMEX.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported MGLD revenue for 2025-06-30 was $30.2M. Net income was -$5.8M. MGLD currently screens at market cap $50.5M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. MGLD currently screens at market cap $50.5M.
Not investment advice. Open the BSX and MGLD stock pages for the full models.
Not investment advice.